| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.2 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.2 |